MSF Supports Patent Challenge To Prevent Johnson & Johnson Extending Protections On TB Drug

Médecins Sans Frontières: TB activists challenge patent in India, in bid to prevent J&J from extending monopoly
“Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. … MSF is urging J&J to refrain from attempts to extend its monopoly that will further delay the availability of quality-assured generic versions of bedaquiline in India, South Africa, and other countries” (2/8).